Detalhe da pesquisa
1.
Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer.
Breast Cancer Res
; 24(1): 97, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36578092
2.
CytoPred: 7-gene pair metric for AML cytogenetic risk prediction.
Brief Bioinform
; 21(1): 348-354, 2020 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30380003
3.
Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells.
J Biol Chem
; 293(50): 19263-19276, 2018 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30337371
4.
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.
Int J Cancer
; 144(8): 2008-2019, 2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30304546
5.
Merkel cell polyomavirus is implicated in a subset of Merkel cell carcinomas, in the Indian subcontinent.
Microb Pathog
; 137: 103778, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31600537
6.
Lung cancer with dual EGFR and ALK driver alterations at baseline: a retrospective observational cohort study.
Acta Oncol
; 61(9): 1143-1147, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972844
7.
Integrated genomics approach to identify biologically relevant alterations in fewer samples.
BMC Genomics
; 16: 936, 2015 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26572163
8.
Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer.
Cancer Res Commun
; 4(2): 404-417, 2024 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315150
9.
Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.
Gene
; 893: 147952, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37918550
10.
Clinical characteristics, outcomes and prognostic factors in KRAS mutant lung cancers: experience from a tertiary care cancer center in India.
Ecancermedicalscience
; 18: 1674, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439805
11.
RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer.
JCO Precis Oncol
; 8: e2300622, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754058
12.
In silico structural analysis of secretory clusterin to assess pathogenicity of mutations identified in the evolutionarily conserved regions.
J Biomol Struct Dyn
; 41(2): 469-478, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34821197
13.
Real-World Evidence of EGFR Targeted Therapy in NSCLC- A Brief Report of Decade Long Single Center Experience.
JTO Clin Res Rep
; 4(11): 100566, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38033811
14.
Association of Cutibacterium acnes with human thyroid cancer.
Front Endocrinol (Lausanne)
; 14: 1152514, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38027096
15.
Understanding the Impact of Population and Cancer Type on Tumor Mutation Burden Scores: A Comprehensive Whole-Exome Study in Cancer Patients From India.
JCO Glob Oncol
; 9: e2300047, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085046
16.
Systemic Therapy in Thyroid Cancer.
Indian J Surg Oncol
; 13(1): 68-80, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462658
17.
Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in Diagnostics.
Diagnostics (Basel)
; 12(5)2022 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626446
18.
Clinical Utility of Liquid Biopsy (Cell-free DNA) Based EGFR Mutation Detection Post treatment Initiation as a Disease Monitoring Tool in Patients With Advanced EGFR-mutant NSCLC.
Clin Lung Cancer
; 23(5): 410-418, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35649817
19.
Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer.
Front Cell Dev Biol
; 10: 957983, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36393868
20.
Treatment pattern and outcomes in de novo T790M-mutated non-small cell lung cancer.
Ecancermedicalscience
; 16: 1385, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35919239